“Botswana Trials Start on AIDS Vaccine Tolerance by Adults”

Return to Vaccination News Home Page

Subscribe to the Vaccination NewsLetter

View past & current Scandals (columns by Sandy Mintz)

Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.

Botswana, which has the highest HIV rate in the world, will soon begin testing the safety of an experimental AIDS vaccine on HIV-negative adults. According to the Botswana-Harvard AIDS Partnership for HIV Research and Education, the trial will involve giving the EP HIV-1090 vaccine to 42 healthy volunteers from Botswana and the United States. Research site director Dr. Tony Villafana said the first phase of the study will assess whether “the vaccine is safe and well-tolerated in humans.”

Return to Vaccination News Home Page

DISCLAIMER: All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice. The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.